More than 75% of adults in a virtual asthma self-management education program had improved asthma control afterward, according to data presented at the American Academy of Allergy, Asthma & Immunology ...
Children with primary immunodeficiencies often had drug allergy labels, almost all of which were not confirmed when evaluated, according to data reported at the American Academy of Allergy, Asthma & ...
One IPO and six SPACs came to market this past week, and one major issuer joined the pipeline as February comes to a close.
Bezuclastinib mean TSS reduction deepens to -32.0 points at 48 weeks of treatment with further improvement shown across all ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top gene therapy stocks to buy according to hedge funds.
Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 inflammation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results